-
Achuthan V, Perreira JM, Sowd GA, Puray-Chavez M, McDougall WM, Paulucci-Holthauzen A, Wu X, Fadel HJ, Poeschla EM, Multani AS, Hughes SH, Sarafianos SG, Brass AL, Engelman AN, 2018: Capsid-CPSF6 interaction licenses nuclear HIV-1 trafficking to sites of viral DNA integration[J]. Cell Host Microbe, 24, e398-.
-
Adamson CS, Ablan SD, Boeras I, Goila-Gaur R, Soheilian F, Nagashima K, Li F, Salzwedel K, Sakalian M, Wild CT, Freed EO, 2006: In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat)[J]. J Virol, 80, 10957-10971. doi: 10.1128/JVI.01369-06
-
Ambrose Z, Aiken C, 2014: HIV-1 uncoating: connection to nuclear entry and regulation by host proteins[J]. Virology, 454-455, 371-379. doi: 10.1016/j.virol.2014.02.004
-
Bhattacharya S, Zhang H, Debnath AK, Cowburn D, 2008: Solution structure of a hydrocarbon stapled peptide inhibitor in complex with monomeric C-terminal domain of HIV-1 capsid[J]. J Biol Chem, 283, 16274-16278. doi: 10.1074/jbc.C800048200
-
Bhattacharya A, Alam SL, Fricke T, Zadrozny K, Sedzicki J, Taylor AB, Demeler B, Pornillos O, Ganser-Pornillos BK, Diaz-Griffero F, Ivanov DN, Yeager M, 2014: Structural basis of HIV-1 capsid recognition by PF74 and CPSF6[J]. Proc Natl Acad Sci USA, 111, 18625-18630. doi: 10.1073/pnas.1419945112
-
Black LR, Aiken C, 2010: TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro[J]. J Virol, 84, 6564-6569. doi: 10.1128/JVI.00210-10
-
Blair WS, Cao J, Fok-Seang J, Griffin P, Isaacson J, Jackson RL, Murray E, Patick AK, Peng Q, Perros M, Pickford C, Wu H, Butler SL, 2009: New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation[J]. Antimicrob Agents Chemother, 53, 5080-5087. doi: 10.1128/AAC.00759-09
-
Blair WS, Pickford C, Irving SL, Brown DG, Anderson M, Bazin R, Cao J, Ciaramella G, Isaacson J, Jackson L, Hunt R, Kjerrstrom A, Nieman JA, Patick AK, Perros M, Scott AD, Whitby K, Wu H, Butler SL, 2010: HIV capsid is a tractable target for small molecule therapeutic intervention[J]. PLoS Pathog, 6, e1001220-. doi: 10.1371/journal.ppat.1001220
-
Borsetti A, Ohagen A, Gottlinger HG, 1998: The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly[J]. J Virol, 72, 9313-9317.
-
Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ, 2008: Identification of host proteins required for HIV infection through a functional genomic screen[J]. Science, 319, 921-926. doi: 10.1126/science.1152725
-
Briggs JA, Grunewald K, Glass B, Forster F, Krausslich HG, Fuller SD, 2006: The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions[J]. Structure, 14, 15-20. doi: 10.1016/j.str.2005.09.010
-
Briggs JA, Riches JD, Glass B, Bartonova V, Zanetti G, Krausslich HG, 2009: Structure and assembly of immature HIV[J]. Proc Natl Acad Sci USA, 106, 11090-11095. doi: 10.1073/pnas.0903535106
-
Buffone C, Schulte B, Opp S, Diaz-Griffero F, 2015: Contribution of MxB oligomerization to HIV-1 capsid binding and restriction[J]. J Virol, 89, 3285-3294. doi: 10.1128/JVI.03730-14
-
Buffone C, Martinez-Lopez A, Fricke T, Opp S, Severgnini M, Cifola I, Petiti L, Frabetti S, Skorupka K, Zadrozny KK, Ganser-Pornillos BK, Pornillos O, Di Nunzio F, Diaz-Griffero F, 2018: Nup153 unlocks the nuclear pore complex for HIV-1 nuclear translocation in nondividing cells[J]. J Virol, 92, e00648-00618.
-
Bui KH, von Appen A, DiGuilio AL, Ori A, Sparks L, Mackmull MT, Bock T, Hagen W, Andres-Pons A, Glavy JS, Beck M, 2013: Integrated structural analysis of the human nuclear pore complex scaffold[J]. Cell, 155, 1233-1243. doi: 10.1016/j.cell.2013.10.055
-
Bukrinskaya A, Brichacek B, Mann A, Stevenson M, 1998: Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton[J]. J Exp Med, 188, 2113-2125. doi: 10.1084/jem.188.11.2113
-
Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M, 1993: A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells[J]. Nature, 365, 666-669. doi: 10.1038/365666a0
-
Burdick RC, Delviks-Frankenberry KA, Chen J, Janaka SK, Sastri J, Hu WS, Pathak VK, 2017: Dynamics and regulation of nuclear import and nuclear movements of HIV-1 complexes[J]. PLoS Pathog, 13, e1006570-. doi: 10.1371/journal.ppat.1006570
-
Busnadiego I, Kane M, Rihn SJ, Preugschas HF, Hughes J, Blanco-Melo D, Strouvelle VP, Zang TM, Willett BJ, Boutell C, Bieniasz PD, Wilson SJ, 2014: Host and viral determinants of Mx2 antiretroviral activity[J]. J Virol, 88, 7738-7752. doi: 10.1128/JVI.00214-14
-
Campbell EM, Hope TJ, 2015: HIV-1 capsid: the multifaceted key player in HIV-1 infection[J]. Nat Rev Microbiol, 13, 471-483. doi: 10.1038/nrmicro3503
-
Carlson LA, Briggs JA, Glass B, Riches JD, Simon MN, Johnson MC, Muller B, Grunewald K, Krausslich HG, 2008: Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis[J]. Cell Host Microbe, 4, 592-599. doi: 10.1016/j.chom.2008.10.013
-
Carnes SK, Sheehan JH, Aiken C, 2018a: Inhibitors of the HIV-1 capsid, a target of opportunity[J]. Curr Opin HIV AIDS, 13, 359-365. doi: 10.1097/COH.0000000000000472
-
Carnes SK, Zhou J, Aiken C, 2018b: HIV-1 engages a dynein-dynactin-BICD2 complex for infection and transport to the nucleus[J]. J Virol, , -. doi: 10.1128/JVI.00358-18:e00358-00318
-
Chen NY, Zhou L, Gane PJ, Opp S, Ball NJ, Nicastro G, Zufferey M, Buffone C, Luban J, Selwood D, Diaz-Griffero F, Taylor I, Fassati A, 2016: HIV-1 capsid is involved in post-nuclear entry steps[J]. Retrovirology, 13, 28-. doi: 10.1186/s12977-016-0262-0
-
Chin CR, Perreira JM, Savidis G, Portmann JM, Aker AM, Feeley EM, Smith MC, Brass AL, 2015: Direct visualization of HIV-1 replication intermediates shows that capsid and CPSF6 modulate HIV-1 intra-nuclear invasion and integration[J]. Cell Rep, 13, 1717-1731. doi: 10.1016/j.celrep.2015.10.036
-
De Iaco A, Luban J, 2011: Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus[J]. Retrovirology, 8, 98-. doi: 10.1186/1742-4690-8-98
-
De Iaco A, Santoni F, Vannier A, Guipponi M, Antonarakis S, Luban J, 2013: TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm[J]. Retrovirology, 10, 20-. doi: 10.1186/1742-4690-10-20
-
Dharan A, Talley S, Tripathi A, Mamede JI, Majetschak M, Hope TJ, Campbell EM, 2016: KIF5B and Nup358 cooperatively mediate the nuclear import of HIV-1 during infection[J]. PLoS Pathog, 12, e1005700-. doi: 10.1371/journal.ppat.1005700
-
Dharan A, Opp S, Abdel-Rahim O, Keceli SK, Imam S, Diaz-Griffero F, Campbell EM, 2017: Bicaudal D2 facilitates the cytoplasmic trafficking and nuclear import of HIV-1 genomes during infection[J]. Proc Natl Acad Sci USA, 114, E10707-E10716. doi: 10.1073/pnas.1712033114
-
Di Nunzio F, Danckaert A, Fricke T, Perez P, Fernandez J, Perret E, Roux P, Shorte S, Charneau P, Diaz-Griffero F, Arhel NJ, 2012: Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration[J]. PLoS ONE, 7, e46037-. doi: 10.1371/journal.pone.0046037
-
Di Nunzio F, Fricke T, Miccio A, Valle-Casuso JC, Perez P, Souque P, Rizzi E, Severgnini M, Mavilio F, Charneau P, Diaz-Griffero F, 2013: Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication[J]. Virology, 440, 8-18. doi: 10.1016/j.virol.2013.02.008
-
Dick RA, Zadrozny KK, Xu C, Schur FKM, Lyddon TD, Ricana CL, Wagner JM, Perilla JR, Ganser-Pornillos BK, Johnson MC, Pornillos O, Vogt VM, 2018: Inositol phosphates are assembly co-factors for HIV-1[J]. Nature, 560, 509-512. doi: 10.1038/s41586-018-0396-4
-
Fader LD, Bethell R, Bonneau P, Bos M, Bousquet Y, Cordingley MG, Coulombe R, Deroy P, Faucher AM, Gagnon A, Goudreau N, Grand-Maitre C, Guse I, Hucke O, Kawai SH, Lacoste JE, Landry S, Lemke CT, Malenfant E, Mason S, Morin S, O'Meara J, Simoneau B, Titolo S, Yoakim C, 2011: Discovery of a 1, 5-dihydrobenzo[b][1, 4]diazepine-2, 4-dione series of inhibitors of HIV-1 capsid assembly[J]. Bioorg Med Chem Lett, 21, 398-404. doi: 10.1016/j.bmcl.2010.10.131
-
Fassati A, 2012: Multiple roles of the capsid protein in the early steps of HIV-1 infection[J]. Virus Res, 170, 15-24. doi: 10.1016/j.virusres.2012.09.012
-
Fassati A, Goff SP, 1999: Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus[J]. J Virol, 73, 8919-8925.
-
Fassati A, Goff SP, 2001: Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1[J]. J Virol, 75, 3626-3635. doi: 10.1128/JVI.75.8.3626-3635.2001
-
Fernandez J, Portilho DM, Danckaert A, Munier S, Becker A, Roux P, Zambo A, Shorte S, Jacob Y, Vidalain PO, Charneau P, Clavel F, Arhel NJ, 2015: Microtubule-associated proteins 1 (MAP1) promote human immunodeficiency virus type Ⅰ (HIV-1) intracytoplasmic routing to the nucleus[J]. J Biol Chem, 290, 4631-4646. doi: 10.1074/jbc.M114.613133
-
Fontana J, Keller PW, Urano E, Ablan SD, Steven AC, Freed EO, 2016: Identification of an HIV-1 mutation in spacer peptide 1 that stabilizes the immature CA-SP1 lattice[J]. J Virol, 90, 972-978. doi: 10.1128/JVI.02204-15
-
Francis AC, Melikyan GB, 2018: Single HIV-1 imaging reveals progression of infection through CA-dependent steps of docking at the nuclear pore, uncoating, and nuclear transport[J]. Cell Host Microbe, 23, 536-548e536. doi: 10.1016/j.chom.2018.03.009
-
Francis AC, Marin M, Shi J, Aiken C, Melikyan GB, 2016: Time-resolved imaging of single HIV-1 uncoating in vitro and in living cells[J]. PLoS Pathog, 12, e1005709-. doi: 10.1371/journal.ppat.1005709
-
Frank GA, Narayan K, Bess JW Jr, Del Prete GQ, Wu X, Moran A, Hartnell LM, Earl LA, Lifson JD, Subramaniam S, 2015: Maturation of the HIV-1 core by a non-diffusional phase transition[J]. Nat Commun, 6, 5854-. doi: 10.1038/ncomms6854
-
Freed EO, 2015: HIV-1 assembly, release and maturation[J]. Nat Rev Microbiol, 13, 484-496. doi: 10.1038/nrmicro3490
-
Freed EO, Martin MA, 1994: HIV-1 infection of non-dividing cells[J]. Nature, 369, 107-108.
-
Freed EO, Englund G, Martin MA, 1995: Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection[J]. J Virol, 69, 3949-3954.
-
Freed EO, Englund G, Maldarelli F, Martin MA (1997) Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell 88:171-173 (discussion 173-174)
-
Fribourgh JL, Nguyen HC, Matreyek KA, Alvarez FJD, Summers BJ, Dewdney TG, Aiken C, Zhang P, Engelman A, Xiong Y, 2014: Structural insight into HIV-1 restriction by MxB[J]. Cell Host Microbe, 16, 627-638. doi: 10.1016/j.chom.2014.09.021
-
Fricke T, Valle-Casuso JC, White TE, Brandariz-Nunez A, Bosche WJ, Reszka N, Gorelick R, Diaz-Griffero F, 2013: The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6[J]. Retrovirology, 10, 46-. doi: 10.1186/1742-4690-10-46
-
Fricke T, White TE, Schulte B, de Souza Aranha Vieira DA, Dharan A, Campbell EM, Brandariz-Nunez A, Diaz-Griffero F, 2014: MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1[J]. Retrovirology, 11, 68-. doi: 10.1186/s12977-014-0068-x
-
Gallay P, Swingler S, Aiken C, Trono D, 1995a: HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator[J]. Cell, 80, 379-388. doi: 10.1016/0092-8674(95)90488-3
-
Gallay P, Swingler S, Song J, Bushman F, Trono D, 1995b: HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase[J]. Cell, 83, 569-576. doi: 10.1016/0092-8674(95)90097-7
-
Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, Hill CP, 1996: Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid[J]. Cell, 87, 1285-1294. doi: 10.1016/S0092-8674(00)81823-1
-
Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP, 1997: Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein[J]. Science, 278, 849-853. doi: 10.1126/science.278.5339.849
-
Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI, 1999: Assembly and analysis of conical models for the HIV-1 core[J]. Science, 283, 80-83. doi: 10.1126/science.283.5398.80
-
Gitti RK, Lee BM, Walker J, Summers MF, Yoo S, Sundquist WI, 1996: Structure of the amino-terminal core domain of the HIV-1 capsid protein[J]. Science, 273, 231-235. doi: 10.1126/science.273.5272.231
-
Goudreau N, Lemke CT, Faucher AM, Grand-Maitre C, Goulet S, Lacoste JE, Rancourt J, Malenfant E, Mercier JF, Titolo S, Mason SW, 2013: Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography[J]. ACS Chem Biol, 8, 1074-1082. doi: 10.1021/cb400075f
-
Goujon C, Moncorge O, Bauby H, Doyle T, Ward CC, Schaller T, Hue S, Barclay WS, Schulz R, Malim MH, 2013: Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection[J]. Nature, 502, 559-562. doi: 10.1038/nature12542
-
Goujon C, Moncorge O, Bauby H, Doyle T, Barclay WS, Malim MH, 2014: Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor[J]. J Virol, 88, 9017-9026. doi: 10.1128/JVI.01269-14
-
Gres AT, Kirby KA, KewalRamani VN, Tanner JJ, Pornillos O, Sarafianos SG, 2015: X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability[J]. Science, 349, 99-103. doi: 10.1126/science.aaa5936
-
Hu WS, Hughes SH, 2012: HIV-1 reverse transcription[J]. Cold Spring Harb Perspect Med, , a006882-.
-
Hulme AE, Perez O, Hope TJ, 2011: Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription[J]. Proc Natl Acad Sci USA, 108, 9975-9980. doi: 10.1073/pnas.1014522108
-
Hulme AE, Kelley Z, Foley D, Hope TJ, 2015: Complementary assays reveal a low level of CA associated with viral complexes in the nuclei of HIV-1-infected cells[J]. J Virol, 89, 5350-5361. doi: 10.1128/JVI.00476-15
-
Jacques DA, McEwan WA, Hilditch L, Price AJ, Towers GJ, James LC, 2016: HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis[J]. Nature, 536, 349-353. doi: 10.1038/nature19098
-
Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, Schoggins JW, Rice CM, Yamashita M, Hatziioannou T, Bieniasz PD, 2013: MX2 is an interferon-induced inhibitor of HIV-1 infection[J]. Nature, 502, 563-566. doi: 10.1038/nature12653
-
Kane M, Rebensburg SV, Takata MA, Zang TM, Yamashita M, Kvaratskhelia M, Bieniasz PD, 2018: Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2[J]. Elife, 7, e35738-. doi: 10.7554/eLife.35738
-
Keller PW, Adamson CS, Heymann JB, Freed EO, Steven AC, 2011: HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice[J]. J Virol, 85, 1420-1428. doi: 10.1128/JVI.01926-10
-
Keller PW, Huang RK, England MR, Waki K, Cheng N, Heymann JB, Craven RC, Freed EO, Steven AC, 2013: A two-pronged structural analysis of retroviral maturation indicates that core formation proceeds by a disassembly-reassembly pathway rather than a displacive transition[J]. J Virol, 87, 13655-13664. doi: 10.1128/JVI.01408-13
-
Kelly BN, Kyere S, Kinde I, Tang C, Howard BR, Robinson H, Sundquist WI, Summers MF, Hill CP, 2007: Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein[J]. J Mol Biol, 373, 355-366. doi: 10.1016/j.jmb.2007.07.070
-
Kim J, Tipper C, Sodroski J, 2011: Role of TRIM5alpha RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus[J]. J Virol, 85, 8116-8132. doi: 10.1128/JVI.00341-11
-
Knockenhauer KE, Schwartz TU, 2016: The nuclear pore complex as a flexible and dynamic gate[J]. Cell, 164, 1162-1171. doi: 10.1016/j.cell.2016.01.034
-
Koh Y, Wu X, Ferris AL, Matreyek KA, Smith SJ, Lee K, KewalRamani VN, Hughes SH, Engelman A, 2013: Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration[J]. J Virol, 87, 648-658. doi: 10.1128/JVI.01148-12
-
Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK, 2008: Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication[J]. Cell, 135, 49-60. doi: 10.1016/j.cell.2008.07.032
-
Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A, 2010: The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase[J]. J Virol, 84, 397-406. doi: 10.1128/JVI.01899-09
-
Kutluay SB, Perez-Caballero D, Bieniasz PD, 2013: Fates of retroviral core components during unrestricted and TRIM5-restricted infection[J]. PLoS Pathog, 9, e1003214-. doi: 10.1371/journal.ppat.1003214
-
Lahaye X, Gentili M, Silvin A, Conrad C, Picard L, Jouve M, Zueva E, Maurin M, Nadalin F, Knott GJ, Zhao B, Du F, Rio M, Amiel J, Fox AH, Li P, Etienne L, Bond CS, Colleaux L, Manel N, 2018: NONO detects the nuclear HIV capsid to promote cGAS-mediated innate immune activation[J]. Cell, 175, e422-.
-
Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, KewalRamani VN, 2010: Flexible use of nuclear import pathways by HIV-1[J]. Cell Host Microbe, 7, 221-233. doi: 10.1016/j.chom.2010.02.007
-
Lee K, Mulky A, Yuen W, Martin TD, Meyerson NR, Choi L, Yu H, Sawyer SL, Kewalramani VN, 2012: HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6[J]. J Virol, 86, 3851-3860. doi: 10.1128/JVI.06607-11
-
Lemke CT, Titolo S, von Schwedler U, Goudreau N, Mercier JF, Wardrop E, Faucher AM, Coulombe R, Banik SS, Fader L, Gagnon A, Kawai SH, Rancourt J, Tremblay M, Yoakim C, Simoneau B, Archambault J, Sundquist WI, Mason SW, 2012: Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein[J]. J Virol, 86, 6643-6655. doi: 10.1128/JVI.00493-12
-
Lemke CT, Titolo S, Goudreau N, Faucher AM, Mason SW, Bonneau P, 2013: A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization[J]. Acta Crystallogr D Biol Crystallogr, 69, 1115-1123. doi: 10.1107/S0907444913006409
-
Li S, Hill CP, Sundquist WI, Finch JT, 2000: Image reconstructions of helical assemblies of the HIV-1 CA protein[J]. Nature, 407, 409-413. doi: 10.1038/35030177
-
Li F, Goila-Gaur R, Salzwedel K, Kilgore NR, Reddick M, Matallana C, Castillo A, Zoumplis D, Martin DE, Orenstein JM, Allaway GP, Freed EO, Wild CT, 2003: PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing[J]. Proc Natl Acad Sci USA, 100, 13555-13560. doi: 10.1073/pnas.2234683100
-
Lienlaf M, Hayashi F, Di Nunzio F, Tochio N, Kigawa T, Yokoyama S, Diaz-Griffero F, 2011: Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha[J]. J Virol, 85, 8725-8737. doi: 10.1128/JVI.00497-11
-
Lingappa JR, Reed JC, Tanaka M, Chutiraka K, Robinson BA, 2014: How HIV-1 Gag assembles in cells: putting together pieces of the puzzle[J]. Virus Res, 193, 89-107. doi: 10.1016/j.virusres.2014.07.001
-
Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C, 2013: The interferon-inducible MxB protein inhibits HIV-1 infection[J]. Cell Host Microbe, 14, 398-410. doi: 10.1016/j.chom.2013.08.015
-
Machara A, Lux V, Kozisek M, Grantz Saskova K, Stepanek O, Kotora M, Parkan K, Pavova M, Glass B, Sehr P, Lewis J, Muller B, Krausslich HG, Konvalinka J, 2016: Specific inhibitors of HIV capsid assembly binding to the C-terminal domain of the capsid protein: evaluation of 2-arylquinazolines as potential antiviral compounds[J]. J Med Chem, 59, 545-558. doi: 10.1021/acs.jmedchem.5b01089
-
Maertens GN, Cook NJ, Wang W, Hare S, Gupta SS, Oztop I, Lee K, Pye VE, Cosnefroy O, Snijders AP, KewalRamani VN, Fassati A, Engelman A, Cherepanov P, 2014: Structural basis for nuclear import of splicing factors by human Transportin 3[J]. Proc Natl Acad Sci USA, 111, 2728-2733. doi: 10.1073/pnas.1320755111
-
Malikov V, da Silva ES, Jovasevic V, Bennett G, de Souza Aranha Vieira DA, Schulte B, Diaz-Griffero F, Walsh D, Naghavi MH, 2015: HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus[J]. Nat Commun, 6, 6660-. doi: 10.1038/ncomms7660
-
Mallery DL, Marquez CL, McEwan WA, Dickson CF, Jacques DA, Anandapadamanaban M, Bichel K, Towers GJ, Saiardi A, Bocking T, James LC, 2018: IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis[J]. Elife, 7, e35335-. doi: 10.7554/eLife.35335
-
Matreyek KA, Engelman A, 2011: The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid[J]. J Virol, 85, 7818-7827. doi: 10.1128/JVI.00325-11
-
Matreyek KA, Yucel SS, Li X, Engelman A, 2013: Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity[J]. PLoS Pathog, 9, e1003693-. doi: 10.1371/journal.ppat.1003693
-
Mattei S, Glass B, Hagen WJ, Krausslich HG, Briggs JA, 2016a: The structure and flexibility of conical HIV-1 capsids determined within intact virions[J]. Science, 354, 1434-1437. doi: 10.1126/science.aah4972
-
Mattei S, Schur FK, Briggs JA, 2016b: Retrovirus maturation—an extraordinary structural transformation[J]. Curr Opin Virol, 18, 27-35. doi: 10.1016/j.coviro.2016.02.008
-
Mattei S, Tan A, Glass B, Muller B, Krausslich HG, Briggs JAG, 2018: High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation[J]. Proc Natl Acad Sci USA, 115, E9401-E9410. doi: 10.1073/pnas.1811237115
-
McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M, Hope TJ, 2002: Visualization of the intracellular behavior of HIV in living cells[J]. J Cell Biol, 159, 441-452. doi: 10.1083/jcb.200203150
-
Meng X, Zhao G, Yufenyuy E, Ke D, Ning J, Delucia M, Ahn J, Gronenborn AM, Aiken C, Zhang P, 2012: Protease cleavage leads to formation of mature trimer interface in HIV-1 capsid[J]. PLoS Pathog, 8, e1002886-. doi: 10.1371/journal.ppat.1002886
-
Miller MD, Farnet CM, Bushman FD, 1997: Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition[J]. J Virol, 71, 5382-5390.
-
Ning J, Erdemci-Tandogan G, Yufenyuy EL, Wagner J, Himes BA, Zhao G, Aiken C, Zandi R, Zhang P, 2016: In vitro protease cleavage and computer simulations reveal the HIV-1 capsid maturation pathway[J]. Nat Commun, 7, 13689-. doi: 10.1038/ncomms13689
-
Novikova M, Adams LJ, Fontana J, Gres AT, Balasubramaniam M, Winkler DC, Kudchodkar SB, Soheilian F, Sarafianos SG, Steven AC, Freed EO, 2018: Identification of a structural element in HIV-1 Gag required for virus particle assembly and maturation[J]. MBio, 9, e01567-01518.
-
Nowicka-Sans B, Protack T, Lin Z, Li Z, Zhang S, Sun Y, Samanta H, Terry B, Liu Z, Chen Y, Sin N, Sit SY, Swidorski JJ, Chen J, Venables BL, Healy M, Meanwell NA, Cockett M, Hanumegowda U, Regueiro-Ren A, Krystal M, Dicker IB, 2016: Identification and characterization of BMS-955176, a second-generation HIV-1 maturation inhibitor with improved potency, antiviral spectrum, and Gag polymorphic coverage[J]. Antimicrob Agents Chemother, 60, 3956-3969. doi: 10.1128/AAC.02560-15
-
Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO, 2004: Phosphatidylinositol (4, 5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane[J]. Proc Natl Acad Sci USA, 101, 14889-14894. doi: 10.1073/pnas.0405596101
-
Pante N, Kann M, 2002: Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm[J]. Mol Biol Cell, 13, 425-434. doi: 10.1091/mbc.01-06-0308
-
Peng K, Muranyi W, Glass B, Laketa V, Yant SR, Tsai L, Cihlar T, Muller B, Krausslich HG, 2014: Quantitative microscopy of functional HIV post-entry complexes reveals association of replication with the viral capsid[J]. Elife, 3, e04114-. doi: 10.7554/eLife.04114
-
Perez-Caballero D, Hatziioannou T, Zhang F, Cowan S, Bieniasz PD, 2005: Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity[J]. J Virol, 79, 15567-15572. doi: 10.1128/JVI.79.24.15567-15572.2005
-
Perrier M, Bertine M, Le Hingrat Q, Joly V, Visseaux B, Collin G, Landman R, Yazdanpanah Y, Descamps D, Charpentier C, 2017: Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients[J]. J Antimicrob Chemother, 72, 2954-2955. doi: 10.1093/jac/dkx208
-
Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M, 2009: X-ray structures of the hexameric building block of the HIV capsid[J]. Cell, 137, 1282-1292. doi: 10.1016/j.cell.2009.04.063
-
Pornillos O, Ganser-Pornillos BK, Yeager M, 2011: Atomic-level modelling of the HIV capsid[J]. Nature, 469, 424-427. doi: 10.1038/nature09640
-
Price AJ, Jacques DA, McEwan WA, Fletcher AJ, Essig S, Chin JW, Halambage UD, Aiken C, James LC, 2014: Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly[J]. PLoS Pathog, 10, e1004459-. doi: 10.1371/journal.ppat.1004459
-
Purdy MD, Shi D, Chrustowicz J, Hattne J, Gonen T, Yeager M, 2018: MicroED structures of HIV-1 Gag CTD-SP1 reveal binding interactions with the maturation inhibitor bevirimat[J]. Proc Natl Acad Sci USA, 115, 13258-13263. doi: 10.1073/pnas.1806806115
-
Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF, 2006: Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly[J]. Proc Natl Acad Sci USA, 103, 11364-11369. doi: 10.1073/pnas.0602818103
-
Schulte B, Buffone C, Opp S, Di Nunzio F, De Souza Aranha Vieira DA, Brandariz-Nunez A, Diaz-Griffero F, 2015: Restriction of HIV-1 requires the N-terminal region of MxB as a capsid-binding motif but not as a nuclear localization signal[J]. J Virol, 89, 8599-8610. doi: 10.1128/JVI.00753-15
-
Schur FK, Hagen WJ, Rumlova M, Ruml T, Muller B, Krausslich HG, Briggs JA, 2015: Structure of the immature HIV-1 capsid in intact virus particles at 8.8 A resolution[J]. Nature, 517, 505-508. doi: 10.1038/nature13838
-
Schur FK, Obr M, Hagen WJ, Wan W, Jakobi AJ, Kirkpatrick JM, Sachse C, Krausslich HG, Briggs JA, 2016: An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation[J]. Science, 353, 506-508. doi: 10.1126/science.aaf9620
-
Sowd GA, Serrao E, Wang H, Wang W, Fadel HJ, Poeschla EM, Engelman AN, 2016: A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin[J]. Proc Natl Acad Sci USA, 113, E1054-E1063. doi: 10.1073/pnas.1524213113
-
Spearman P, 2016: HIV-1 Gag as an antiviral target: development of assembly and maturation inhibitors[J]. Curr Top Med Chem, 16, 1154-1166.
-
Sticht J, Humbert M, Findlow S, Bodem J, Muller B, Dietrich U, Werner J, Krausslich HG, 2005: A peptide inhibitor of HIV-1 assembly in vitro[J]. Nat Struct Mol Biol, 12, 671-677. doi: 10.1038/nsmb964
-
Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J, 2004: The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys[J]. Nature, 427, 848-853. doi: 10.1038/nature02343
-
Stultz RD, Cenker JJ, McDonald D, 2017: Imaging HIV-1 genomic DNA from entry through productive infection[J]. J Virol, 91, e00034-00017.
-
Sundquist WI, Krausslich HG, 2012: HIV-1 assembly, budding, and maturation[J]. Cold Spring Harb Perspect Med, 2, a006924-.
-
Tang C, Loeliger E, Kinde I, Kyere S, Mayo K, Barklis E, Sun Y, Huang M, Summers MF, 2003: Antiviral inhibition of the HIV-1 capsid protein[J]. J Mol Biol, 327, 1013-1020. doi: 10.1016/S0022-2836(03)00289-4
-
Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, Summers MF, 2004: Entropic switch regulates myristate exposure in the HIV-1 matrix protein[J]. Proc Natl Acad Sci USA, 101, 517-522. doi: 10.1073/pnas.0305665101
-
Tedbury PR, Freed EO, 2015: HIV-1 gag: an emerging target for antiretroviral therapy[J]. Curr Top Microbiol Immunol, 389, 171-201.
-
Ternois F, Sticht J, Duquerroy S, Krausslich HG, Rey FA, 2005: The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor[J]. Nat Struct Mol Biol, 12, 678-682. doi: 10.1038/nsmb967
-
Tse WC, Link JO, Mulato A, Niedziela-Majka A, Rowe W, Somoza JR, Villasenor AG, Yant SR, Zhang JR, Zheng J (2017) Discovery of novel potent HIV capsid inhibitors with long-acting potential. In: Conference on retroviruses and opportunistic infections Abstract 38—new HIV drugs, formulations, combinations, and resistance
-
Urano E, Ablan SD, Mandt R, Pauly GT, Sigano DM, Schneider JP, Martin DE, Nitz TJ, Wild CT, Freed EO, 2016: Alkyl amine bevirimat derivatives are potent and broadly active HIV-1 maturation inhibitors[J]. Antimicrob Agents Chemother, 60, 190-197. doi: 10.1128/AAC.02121-15
-
Valle-Casuso JC, Di Nunzio F, Yang Y, Reszka N, Lienlaf M, Arhel N, Perez P, Brass AL, Diaz-Griffero F, 2012: TNPO3 is required for HIV-1 replication after nuclear import but prior to integration and binds the HIV-1 core[J]. J Virol, 86, 5931-5936. doi: 10.1128/JVI.00451-12
-
Vollmer B, Lorenz M, Moreno-Andres D, Bodenhofer M, De Magistris P, Astrinidis SA, Schooley A, Flotenmeyer M, Leptihn S, Antonin W, 2015: Nup153 recruits the Nup107-160 complex to the inner nuclear membrane for interphasic nuclear pore complex assembly[J]. Dev Cell, 33, 717-728. doi: 10.1016/j.devcel.2015.04.027
-
von Schwedler U, Kornbluth RS, Trono D, 1994: The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes[J]. Proc Natl Acad Sci USA, 91, 6992-6996. doi: 10.1073/pnas.91.15.6992
-
von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR, Sundquist WI, 1998: Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly[J]. EMBO J, 17, 1555-1568. doi: 10.1093/emboj/17.6.1555
-
Wagner JM, Zadrozny KK, Chrustowicz J, Purdy MD, Yeager M, Ganser-Pornillos BK, Pornillos O, 2016: Crystal structure of an HIV assembly and maturation switch[J]. Elife, 5, e17063-. doi: 10.7554/eLife.17063
-
Wagner JM, Christensen DE, Bhattacharya A, Dawidziak DM, Roganowicz MD, Wan Y, Pumroy RA, Demeler B, Ivanov DN, Ganser-Pornillos BK, Sundquist WI, Pornillos O, 2018: General model for retroviral capsid pattern recognition by TRIM5 proteins[J]. J Virol, 92, e01563-01517.
-
Waki K, Durell SR, Soheilian F, Nagashima K, Butler SL, Freed EO, 2012: Structural and functional insights into the HIV-1 maturation inhibitor binding pocket[J]. PLoS Pathog, 8, e1002997-. doi: 10.1371/journal.ppat.1002997
-
Walde S, Thakar K, Hutten S, Spillner C, Nath A, Rothbauer U, Wiemann S, Kehlenbach RH, 2012: The nucleoporin Nup358/RanBP2 promotes nuclear import in a cargo- and transport receptor-specific manner[J]. Traffic, 13, 218-233. doi: 10.1111/j.1600-0854.2011.01302.x
-
Walsh D, Naghavi MH, 2019: Exploitation of cytoskeletal networks during early viral infection[J]. Trends Microbiol, 27, 39-50. doi: 10.1016/j.tim.2018.06.008
-
Walther TC, Pickersgill HS, Cordes VC, Goldberg MW, Allen TD, Mattaj IW, Fornerod M, 2002: The cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein import[J]. J Cell Biol, 158, 63-77. doi: 10.1083/jcb.200202088
-
Wang W, Zhou J, Halambage UD, Jurado KA, Jamin AV, Wang Y, Engelman AN, Aiken C, 2017: Inhibition of HIV-1 maturation via small-molecule targeting of the amino-terminal domain in the viral capsid protein[J]. J Virol, 91, e02155-02116.
-
Woodward CL, Cheng SN, Jensen GJ, 2015: Electron cryotomography studies of maturing HIV-1 particles reveal the assembly pathway of the viral core[J]. J Virol, 89, 1267-1277. doi: 10.1128/JVI.02997-14
-
Wright ER, Schooler JB, Ding HJ, Kieffer C, Fillmore C, Sundquist WI, Jensen GJ, 2007: Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells[J]. EMBO J, 26, 2218-2226. doi: 10.1038/sj.emboj.7601664
-
Xu H, Franks T, Gibson G, Huber K, Rahm N, Strambio De Castillia C, Luban J, Aiken C, Watkins S, Sluis-Cremer N, Ambrose Z, 2013: Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay[J]. Retrovirology, 10, 70-. doi: 10.1186/1742-4690-10-70
-
Yamashita M, Emerman M, 2004: Capsid is a dominant determinant of retrovirus infectivity in nondividing cells[J]. J Virol, 78, 5670-5678. doi: 10.1128/JVI.78.11.5670-5678.2004
-
Yamashita M, Engelman AN, 2017: Capsid-dependent host factors in HIV-1 infection[J]. Trends Microbiol, 25, 741-755. doi: 10.1016/j.tim.2017.04.004
-
Yamashita M, Perez O, Hope TJ, Emerman M, 2007: Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells[J]. PLoS Pathog, 3, 1502-1510.
-
Yap MW, Dodding MP, Stoye JP, 2006: Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle[J]. J Virol, 80, 4061-4067. doi: 10.1128/JVI.80.8.4061-4067.2006
-
Zhang H, Zhao Q, Bhattacharya S, Waheed AA, Tong X, Hong A, Heck S, Curreli F, Goger M, Cowburn D, Freed EO, Debnath AK, 2008: A cell-penetrating helical peptide as a potential HIV-1 inhibitor[J]. J Mol Biol, 378, 565-580. doi: 10.1016/j.jmb.2008.02.066
-
Zhang W, Cao S, Martin JL, Mueller JD, Mansky LM, 2015: Morphology and ultrastructure of retrovirus particles[J]. AIMS Biophys, 2, 343-369. doi: 10.3934/biophy.2015.3.343
-
Zhao G, Perilla JR, Yufenyuy EL, Meng X, Chen B, Ning J, Ahn J, Gronenborn AM, Schulten K, Aiken C, Zhang P, 2013: Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics[J]. Nature, 497, 643-646. doi: 10.1038/nature12162
-
Zhou J, Yuan X, Dismuke D, Forshey BM, Lundquist C, Lee KH, Aiken C, Chen CH, 2004: Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation[J]. J Virol, 78, 922-929. doi: 10.1128/JVI.78.2.922-929.2004
-
Zhou L, Sokolskaja E, Jolly C, James W, Cowley SA, Fassati A, 2011: Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration[J]. PLoS Pathog, 7, e1002194-. doi: 10.1371/journal.ppat.1002194